Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
2 evidence topics · 2 sources
Investigational formulation in PRAX-944-221
| Attribute | Quoted protocol information |
|---|---|
| Dosage form | “Modified-release tablet” |
| Unit strength | “20 mg” |
| Route | “Oral” |
Commercial dosage forms and strengths
No evidence found.
Material safety data sheet
No evidence found.